What is happening. As a fat-soluble vitamin absorbed through the same micellar lipid pathway affected by ezetimibe, vitamin E (tocopherol) absorption may be modestly reduced. Some pharmacology data show small decreases in serum alpha-tocopherol and carotenoids with cholesterol absorption inhibitors. The effect is generally minor and is partly offset because circulating tocopherol is carried on lipoproteins whose levels also fall with therapy.
Mechanism. Ezetimibe reduces NPC1L1-mediated intestinal sterol uptake and the efficiency of micellar fat absorption, which can lower co-absorbed lipophilic micronutrients such as alpha-tocopherol and carotenoids.
Recommendation. No change to standard vitamin E intake is needed. Patients relying on vitamin E supplementation for a specific indication can take it with a fat-containing meal to optimize uptake. Routine monitoring is not required for typical dietary or supplemental doses.